✦ LIBER ✦

Brentuximab vedotin (SGN-35) in patients with transplant-naive relapsed/refractory Hodgkin lymphoma

✍ Scribed by Sasse, Stephanie; Rothe, Achim; Goergen, Helen; Eichenauer, Dennis A.; Lohri, Andreas; Kreher, Stephan; Jäger, Ulrich; Bangard, Christopher; Kuhnert, Georg; Böll, Boris; von Tresckow, Bastian; Engert, Andreas

Book ID: 120065633
Publisher: Informa plc
Year: 2013
Tongue: English
Weight: 508 KB
Volume: 54
Category: Article
ISSN: 1042-8194
DOI: 10.3109/10428194.2013.775434

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Brentuximab vedotin (SGN-35) in Hodgkin

Brentuximab vedotin (SGN-35) in Hodgkin lymphoma patients with relapsed after autologous peripheral blood stem-cell transplantation

✍ Erdem, G.; Karadurmus, N.; Ozaydin, S.; Karacalioglu, A.O.; Yeginer, C.; Ozturk, 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Resolution of malignant cutaneous lesion

Resolution of malignant cutaneous lesions with brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large cell lymphoma

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Brentuximab Vedotin (SGN-35) in Patients

Brentuximab Vedotin (SGN-35) in Patients With Relapsed or Refractory Systemic Anaplastic Large-Cell Lymphoma: Results of a Phase II Study

✍ Pro, B.; Advani, R.; Brice, P.; Bartlett, N. L.; Rosenblatt, J. D.; Illidge, T.; 📂 Article 📅 2012 🏛 American Society of Clinical Oncology 🌐 English ⚖ 395 KB

Durable complete remission after brentux

Durable complete remission after brentuximab vedotin in a patient with relapsed and refractory Hodgkin lymphoma (HL)

✍ Prof. Dr. Johannes Drach MD, Ihor Huk… 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 963 KB

Brentuximab vedotin followed by allogene

Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma

✍ Garciaz, Sylvain; Coso, Diane; Peyrade, Frederic; Fürst, Sabine; Duran, Ségolène 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

Reduced-Intensity Conditioning and Allog

Reduced-Intensity Conditioning and Allogeneic Stem Cell Transplantation For Relapsed/Refractory Hodgkin Lymphoma In The Brentuximab Vedotin Era

✍ Anderlini, Paolo; Saliba, Rima; Ledesma, Celina; Chancoco, Christina M.; Alexand 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 55 KB